2021 Form 10-K Financial Statement

#000143774922007396 Filed on March 28, 2022

View on sec.gov

Income Statement

Concept 2021 2020 Q4 2020
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $17.71M $3.950M $21.82M
YoY Change -18.85% -68.22% -11.26%
% of Gross Profit
Research & Development $1.615M
YoY Change
% of Gross Profit
Depreciation & Amortization $184.0K $50.00K $196.0K
YoY Change -6.12% -44.44% -21.91%
% of Gross Profit
Operating Expenses $19.51M $4.000M $22.01M
YoY Change -11.38% -68.05% -37.11%
Operating Profit -$19.51M -$22.01M
YoY Change -11.38% -37.11%
Interest Expense $2.000K $0.00 $243.0K
YoY Change -99.18% -100.0% -85.86%
% of Operating Profit
Other Income/Expense, Net -$2.532M $1.720M $7.683M
YoY Change -132.96% -191.01% -983.1%
Pretax Income -$22.04M -$2.280M -$14.33M
YoY Change 53.8% -83.57% -60.05%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$22.04M -$2.280M -$14.33M
YoY Change 53.81% -83.57% -60.05%
Net Earnings / Revenue
Basic Earnings Per Share -$0.34
Diluted Earnings Per Share -$184.9K -$19.36K -$121.9K
COMMON SHARES
Basic Shares Outstanding 119.2M 120.5M 117.5M
Diluted Shares Outstanding 119.2M 117.5M

Balance Sheet

Concept 2021 2020 Q4 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.55M $22.61M $22.60M
YoY Change 13.06% -70.99% 43.95%
Cash & Equivalents $25.55M $22.61M $22.60M
Short-Term Investments $0.00
Other Short-Term Assets $332.0K $267.0K $400.0K
YoY Change -17.0% -29.92% 33.33%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $25.88M $23.28M $23.00M
YoY Change 12.54% -70.46% 43.75%
LONG-TERM ASSETS
Property, Plant & Equipment $174.4M $161.7M $162.1M
YoY Change 7.59% 20.11% 19.54%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $0.00
YoY Change -100.0% -100.0%
Other Assets $16.30M
YoY Change 141.54%
Total Long-Term Assets $196.2M $178.4M $178.7M
YoY Change 9.8% 25.28% -12.91%
TOTAL ASSETS
Total Short-Term Assets $25.88M $23.28M $23.00M
Total Long-Term Assets $196.2M $178.4M $178.7M
Total Assets $222.1M $201.7M $201.7M
YoY Change 10.12% -8.83% -8.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $281.0K $207.0K $200.0K
YoY Change 40.5% -98.26% -98.32%
Accrued Expenses $6.387M $1.500M $1.500M
YoY Change 325.8% -84.21% -84.21%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.668M $5.143M $1.700M
YoY Change 292.24% -76.13% -92.06%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $27.15M $22.92M $27.30M
YoY Change -0.57% 123.77%
Total Long-Term Liabilities $27.15M $22.92M $27.30M
YoY Change -0.57% 123.77%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.668M $5.143M $1.700M
Total Long-Term Liabilities $27.15M $22.92M $27.30M
Total Liabilities $33.81M $28.93M $28.90M
YoY Change 17.0% -13.84% -13.99%
SHAREHOLDERS EQUITY
Retained Earnings -$148.0M
YoY Change 10.72%
Common Stock $12.00K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.031M
YoY Change 50.51%
Treasury Stock Shares $249.7B
Shareholders Equity $188.3M $60.43M $172.7M
YoY Change
Total Liabilities & Shareholders Equity $222.1M $201.7M $201.7M
YoY Change 10.12% -8.83% -8.82%

Cashflow Statement

Concept 2021 2020 Q4 2020
OPERATING ACTIVITIES
Net Income -$22.04M -$2.280M -$14.33M
YoY Change 53.81% -83.57% -60.05%
Depreciation, Depletion And Amortization $184.0K $50.00K $196.0K
YoY Change -6.12% -44.44% -21.91%
Cash From Operating Activities -$17.96M -$3.500M -$26.25M
YoY Change -31.59% -52.83% -35.5%
INVESTING ACTIVITIES
Capital Expenditures $12.11M -$3.780M $32.35M
YoY Change -62.58% -55.89% 59.35%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $61.78M
YoY Change -100.0% -100.0% 488.94%
Cash From Investing Activities -$18.53M -$3.790M $18.52M
YoY Change -200.07% -87.57% -210.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$273.0K $346.0K
YoY Change -178.9% -46.77%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $39.44M -40.00K $14.60M
YoY Change 170.05% -100.08% -79.13%
NET CHANGE
Cash From Operating Activities -$17.96M -3.500M -$26.25M
Cash From Investing Activities -$18.53M -3.790M $18.52M
Cash From Financing Activities $39.44M -40.00K $14.60M
Net Change In Cash $2.944M -7.330M $6.872M
YoY Change -57.16% -161.65% -45.32%
FREE CASH FLOW
Cash From Operating Activities -$17.96M -$3.500M -$26.25M
Capital Expenditures $12.11M -$3.780M $32.35M
Free Cash Flow -$30.07M $280.0K -$58.61M
YoY Change -48.7% -75.65% -3.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Auditor Location
AuditorLocation
Houston, Texas
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
480000000.0
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
480000000.0
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
120800000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
120800000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
117800000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
117800000
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
346126000000
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
249742000000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-22012000 USD
CY2020 next Gain Loss On Revaluation Of Warrants
GainLossOnRevaluationOfWarrants
7870000 USD
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7683000 USD
CY2020 us-gaap Dividends Preferred Stock
DividendsPreferredStock
14327000 USD
CY2020 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
128000 USD
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28784000 USD
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
CY2020Q4 us-gaap Deferred Compensation Sharebased Arrangements Liability Current And Noncurrent
DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent
200000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021 us-gaap Open Tax Year
OpenTaxYear
2016 2017 2018 2019 2020 2021
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25552000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22608000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
835000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
670000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
26387000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
23278000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
173816000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
161662000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
590000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
429000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
21312000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
16299000 USD
CY2021Q4 us-gaap Assets
Assets
222105000 USD
CY2020Q4 us-gaap Assets
Assets
201668000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
281000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
207000 USD
CY2021Q4 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
182000 USD
CY2020Q4 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
182000 USD
CY2021Q4 next Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
5791000 USD
CY2020Q4 next Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
1032000 USD
CY2021Q4 next Current Common Stock Warrant Liabilities
CurrentCommonStockWarrantLiabilities
1376000 USD
CY2020Q4 next Current Common Stock Warrant Liabilities
CurrentCommonStockWarrantLiabilities
3290000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
596000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
432000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8226000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5143000 USD
CY2021Q4 next Non Current Common Stock Warrant Liabilities
NonCurrentCommonStockWarrantLiabilities
2587000 USD
CY2020Q4 next Non Current Common Stock Warrant Liabilities
NonCurrentCommonStockWarrantLiabilities
874000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
23000000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
22916000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
33813000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
28933000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
12000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
12000 USD
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1315000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1031000 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
191264000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
209481000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-170069000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-148030000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
19892000 USD
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-18000 USD
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2532000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-22039000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-14329000 USD
CY2021 us-gaap Dividends Preferred Stock
DividendsPreferredStock
18294000 USD
CY2021 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
63000 USD
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-40396000 USD
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
60432000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
222105000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
201668000 USD
CY2021 us-gaap Revenues
Revenues
0 USD
CY2020 us-gaap Revenues
Revenues
0 USD
CY2021 next General And Administrative Expense Recovery
GeneralAndAdministrativeExpenseRecovery
16803000 USD
CY2020 next General And Administrative Expense Recovery
GeneralAndAdministrativeExpenseRecovery
20213000 USD
CY2021 next Development Expense
DevelopmentExpense
1615000 USD
CY2020 next Development Expense
DevelopmentExpense
0 USD
CY2021 next Land Option And Lease Expense
LandOptionAndLeaseExpense
905000 USD
CY2020 next Land Option And Lease Expense
LandOptionAndLeaseExpense
1603000 USD
CY2021 us-gaap Depreciation
Depreciation
184000 USD
CY2020 us-gaap Depreciation
Depreciation
196000 USD
CY2021 us-gaap Operating Expenses
OperatingExpenses
19507000 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
22012000 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-19507000 USD
CY2021 next Gain Loss On Revaluation Of Warrants
GainLossOnRevaluationOfWarrants
-2533000 USD
CY2021 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0 USD
CY2020 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-412000 USD
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
2000 USD
CY2020 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
243000 USD
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000 USD
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
119201
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
117524
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
89717000 USD
CY2020 next Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost Equity Awards
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCostEquityAwards
-155000 USD
CY2020 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
346000 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
14327000 USD
CY2020 next Adjustments To Additional Paid In Capital Deemed Dividends
AdjustmentsToAdditionalPaidInCapitalDeemedDividends
-128000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-14329000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
60432000 USD
CY2021 next Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost Equity Awards
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCostEquityAwards
-4541000 USD
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2021 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
284000 USD
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
316000 USD
CY2021 next Adjustments To Additional Paid In Capital Warrants Exercised
AdjustmentsToAdditionalPaidInCapitalWarrantsExercised
4365000 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
18294000 USD
CY2021 next Adjustments To Additional Paid In Capital Deemed Dividends
AdjustmentsToAdditionalPaidInCapitalDeemedDividends
-63000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-22039000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
19892000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-22039000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-14329000 USD
CY2021 us-gaap Depreciation
Depreciation
184000 USD
CY2020 us-gaap Depreciation
Depreciation
196000 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
-4313000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
-341000 USD
CY2021 next Gain Loss On Revaluation Of Warrants
GainLossOnRevaluationOfWarrants
-2533000 USD
CY2020 next Gain Loss On Revaluation Of Warrants
GainLossOnRevaluationOfWarrants
7870000 USD
CY2021 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
-0 USD
CY2020 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
-423000 USD
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
551000 USD
CY2020 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1230000 USD
CY2021 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
1416000 USD
CY2020 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
1360000 USD
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
186000 USD
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-191000 USD
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-26000 USD
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-370000 USD
CY2021 next Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-548000 USD
CY2020 next Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-874000 USD
CY2021 next Increase Decrease In Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccruedExpensesAndOtherLiabilities
4468000 USD
CY2020 next Increase Decrease In Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccruedExpensesAndOtherLiabilities
-5869000 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17960000 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26253000 USD
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12105000 USD
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
32352000 USD
CY2021 next Investing Activities Other Noncurrent Assets
InvestingActivitiesOtherNoncurrentAssets
6429000 USD
CY2020 next Investing Activities Other Noncurrent Assets
InvestingActivitiesOtherNoncurrentAssets
10911000 USD
CY2021 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0 USD
CY2020 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
61972000 USD
CY2021 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
-0 USD
CY2020 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
188000 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18534000 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
18521000 USD
CY2021 next Proceeds From Divestiture Of Businesses Financing Activities
ProceedsFromDivestitureOfBusinessesFinancingActivities
0 USD
CY2020 next Proceeds From Divestiture Of Businesses Financing Activities
ProceedsFromDivestitureOfBusinessesFinancingActivities
15000000 USD
CY2021 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
39500000 USD
CY2020 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
0 USD
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
557000 USD
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
268000 USD
CY2020 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
-0 USD
CY2021 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
67000 USD
CY2020 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
50000 USD
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
284000 USD
CY2020 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
346000 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
39438000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14604000 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2944000 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6872000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22608000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15736000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25552000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22608000 USD
CY2021 next Capital Expenditures Incurred But Not Yet Paid Included In Accounts Payable
CapitalExpendituresIncurredButNotYetPaidIncludedInAccountsPayable
117000 USD
CY2020 next Capital Expenditures Incurred But Not Yet Paid Included In Accounts Payable
CapitalExpendituresIncurredButNotYetPaidIncludedInAccountsPayable
16000 USD
CY2021 next Capital Expenditures Incurred But Not Yet Paid Included In Accrued Liabilities
CapitalExpendituresIncurredButNotYetPaidIncludedInAccruedLiabilities
926000 USD
CY2020 next Capital Expenditures Incurred But Not Yet Paid Included In Accrued Liabilities
CapitalExpendituresIncurredButNotYetPaidIncludedInAccruedLiabilities
650000 USD
CY2021 next Pipeline Assets In Exchange For Other Non Current Liabilities
PipelineAssetsInExchangeForOtherNonCurrentLiabilities
84000 USD
CY2020 next Pipeline Assets In Exchange For Other Non Current Liabilities
PipelineAssetsInExchangeForOtherNonCurrentLiabilities
7916000 USD
CY2021 next Noncash Paidinkind Dividends Convertible Preferred Stock
NoncashPaidinkindDividendsConvertiblePreferredStock
18227000 USD
CY2020 next Noncash Paidinkind Dividends Convertible Preferred Stock
NoncashPaidinkindDividendsConvertiblePreferredStock
14277000 USD
CY2021 next Noncash Accretion Of Deemed Dividends Convertible Preferred Stock
NoncashAccretionOfDeemedDividendsConvertiblePreferredStock
63000 USD
CY2020 next Noncash Accretion Of Deemed Dividends Convertible Preferred Stock
NoncashAccretionOfDeemedDividendsConvertiblePreferredStock
128000 USD
CY2021 next Liabilities Accrued For Equity Issuance Costs
LiabilitiesAccruedForEquityIssuanceCosts
35000 USD
CY2020 next Liabilities Accrued For Equity Issuance Costs
LiabilitiesAccruedForEquityIssuanceCosts
0 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25600000 USD
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>Use of Estimates</b></p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">The preparation of Consolidated Financial Statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the amounts reported in the Consolidated Financial Statements and the accompanying notes. Management evaluates its estimates and related assumptions regularly, including those related to the value of property, plant and equipment, income taxes including valuation allowances for net deferred tax assets, share-based compensation and fair value measurements. Changes in facts and circumstances or additional information <em style="font: inherit;"> may </em>result in revised estimates, and actual results <em style="font: inherit;"> may </em>differ from these estimates.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"> </p>
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 7.2pt; text-align: left; text-indent: -9pt;"><b>Concentrations of Credit Risk</b></p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">Financial instruments that potentially subject us to a concentration of credit risk consist principally of cash and cash equivalents. We maintain cash and cash equivalent balances with a single financial institution, which <em style="font: inherit;"> may </em>at times be in excess of federally insured levels. We have <em style="font: inherit;">not</em> incurred losses related to these cash and cash equivalent balances to date.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"> </p>
CY2021Q4 next Prepaid Subscriptions
PrepaidSubscriptions
85000 USD
CY2020Q4 next Prepaid Subscriptions
PrepaidSubscriptions
29000 USD
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
272000 USD
CY2020Q4 us-gaap Prepaid Insurance
PrepaidInsurance
314000 USD
CY2021Q4 next Prepaid Marketing And Sponsorships
PrepaidMarketingAndSponsorships
60000 USD
CY2020Q4 next Prepaid Marketing And Sponsorships
PrepaidMarketingAndSponsorships
60000 USD
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
418000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
267000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
835000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
670000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
173816000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
161662000 USD
CY2021 us-gaap Depreciation
Depreciation
184000 USD
CY2020 us-gaap Depreciation
Depreciation
196000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
590000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
429000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
596000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
432000 USD
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
596000 USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
432000 USD
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
627000 USD
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
1275000 USD
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
278000 USD
CY2020 us-gaap Short Term Lease Cost
ShortTermLeaseCost
319000 USD
CY2021 next Land Option Lease Cost
LandOptionLeaseCost
0 USD
CY2020 next Land Option Lease Cost
LandOptionLeaseCost
9000 USD
CY2021 us-gaap Lease Cost
LeaseCost
905000 USD
CY2020 us-gaap Lease Cost
LeaseCost
1603000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
633000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
0 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
0 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
0 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
0 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
0 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
633000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
37000 USD
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
596000 USD
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
624000 USD
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
1004000 USD
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
712000 USD
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
605000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
16299000 USD
CY2021Q4 next Permitting Costs Noncurrent
PermittingCostsNoncurrent
7609000 USD
CY2020Q4 next Permitting Costs Noncurrent
PermittingCostsNoncurrent
7385000 USD
CY2021Q4 next Enterprise Resource Planning System Noncurrent
EnterpriseResourcePlanningSystemNoncurrent
389000 USD
CY2020Q4 next Enterprise Resource Planning System Noncurrent
EnterpriseResourcePlanningSystemNoncurrent
1805000 USD
CY2021Q4 next Site Lease Initial Direct Costs
SiteLeaseInitialDirectCosts
13314000 USD
CY2020Q4 next Site Lease Initial Direct Costs
SiteLeaseInitialDirectCosts
7109000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
21312000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4358000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14000 USD
CY2021Q4 next Project Asset Costs Current
ProjectAssetCostsCurrent
926000 USD
CY2020Q4 next Project Asset Costs Current
ProjectAssetCostsCurrent
650000 USD
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
70000 USD
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
5000 USD
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
437000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
363000 USD
CY2021Q4 next Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
5791000 USD
CY2020Q4 next Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
1032000 USD
CY2021 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
39500000 USD
CY2021 next Payments Of Equity Issuance Costs
PaymentsOfEquityIssuanceCosts
-62000 USD
CY2021 next Proceeds From Issuance Of Convertible Preferred Stock And Common Stock Warrant Net
ProceedsFromIssuanceOfConvertiblePreferredStockAndCommonStockWarrantNet
39438000 USD
CY2021 next Gain Loss On Revaluation Of Warrants
GainLossOnRevaluationOfWarrants
-2500000 USD
CY2020 next Gain Loss On Revaluation Of Warrants
GainLossOnRevaluationOfWarrants
7900000 USD
CY2021 next Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost Equity Awards
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCostEquityAwards
-4541000 USD
CY2021 next Stock Issued During Period Exercise Of Warrants Shares
StockIssuedDuringPeriodExerciseOfWarrantsShares
1500000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119201000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
117524000
CY2021 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2020 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119201000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
117524000
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
46705000
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
31609000
CY2021 next Securities Excluded From Computation Of Earnings Per Share Amount Performance Conditions
SecuritiesExcludedFromComputationOfEarningsPerShareAmountPerformanceConditions
8300000
CY2020 next Securities Excluded From Computation Of Earnings Per Share Amount Performance Conditions
SecuritiesExcludedFromComputationOfEarningsPerShareAmountPerformanceConditions
2100000
CY2015Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
17.50
CY2015 next Number Of Trading Days Of Share Price
NumberOfTradingDaysOfSharePrice
P20D
CY2015 next Total Number Of Trading Days Considered
TotalNumberOfTradingDaysConsidered
P30D
CY2020 next Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost Equity Awards
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCostEquityAwards
-155000 USD
CY2021 next Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost Liability Awards
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCostLiabilityAwards
0 USD
CY2020 next Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost Liability Awards
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCostLiabilityAwards
0 USD
CY2021 next Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost
-4541000 USD
CY2020 next Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost
-155000 USD
CY2021 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
-228000 USD
CY2020 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
186000 USD
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-4313000 USD
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-341000 USD
CY2021 next Percentage Of Fid Bonus Settlement Of Shares
PercentageOfFIDBonusSettlementOfShares
1.10 pure
CY2021Q4 us-gaap Deferred Compensation Sharebased Arrangements Liability Current And Noncurrent
DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent
200000 USD
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
25100000 USD
CY2021 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.02 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.04 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.03 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.17 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.20 pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2020Q4 next Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
91000 USD
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
55000 USD
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
54000 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
26461000 USD
CY2021Q4 next Deferred Tax Assets Operating Loss Carryforwards And Credits
DeferredTaxAssetsOperatingLossCarryforwardsAndCredits
25742000 USD
CY2020Q4 next Deferred Tax Assets Operating Loss Carryforwards And Credits
DeferredTaxAssetsOperatingLossCarryforwardsAndCredits
20698000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
570000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
0 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2053000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3813000 USD
CY2021Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
753000 USD
CY2020Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
725000 USD
CY2021Q4 next Deferred Tax Assets Common Stock Warrant Liabilities
DeferredTaxAssetsCommonStockWarrantLiabilities
83000 USD
CY2020Q4 next Deferred Tax Assets Common Stock Warrant Liabilities
DeferredTaxAssetsCommonStockWarrantLiabilities
0 USD
CY2021Q4 next Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
125000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
22669000 USD
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2920000 USD
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2712000 USD
CY2021Q4 next Deferred Tax Liabilities Common Stock Warrant Liabilities
DeferredTaxLiabilitiesCommonStockWarrantLiabilities
-0 USD
CY2020Q4 next Deferred Tax Liabilities Common Stock Warrant Liabilities
DeferredTaxLiabilitiesCommonStockWarrantLiabilities
1129000 USD
CY2021Q4 next Deferred Tax Liabilities Operating Leases
DeferredTaxLiabilitiesOperatingLeases
2920000 USD
CY2020Q4 next Deferred Tax Liabilities Operating Leases
DeferredTaxLiabilitiesOperatingLeases
1583000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2920000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2712000 USD
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
122600000 USD
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
26100000 USD

Files In Submission

Name View Source Status
0001437749-22-007396-index-headers.html Edgar Link pending
0001437749-22-007396-index.html Edgar Link pending
0001437749-22-007396.txt Edgar Link pending
0001437749-22-007396-xbrl.zip Edgar Link pending
abbreviatedorgchartforkandqm.jpg Edgar Link pending
ex_312276.htm Edgar Link pending
ex_312277.htm Edgar Link pending
ex_312278.htm Edgar Link pending
ex_312279.htm Edgar Link pending
ex_312280.htm Edgar Link pending
ex_312281.htm Edgar Link pending
ex_349797.htm Edgar Link pending
ex_349798.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
next-20211231.xsd Edgar Link pending
next-20211231_cal.xml Edgar Link unprocessable
next-20211231_def.xml Edgar Link unprocessable
next-20211231_lab.xml Edgar Link unprocessable
next-20211231_pre.xml Edgar Link unprocessable
next20211231_10k.htm Edgar Link pending
next20211231_10k_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending